Metabolomic changes in human adipose tissue derived products following non-enzymatic microfacturing

M. Garcia-Contreras, F. Messaggio, Armando J Mendez, Camillo Ricordi

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

OBJECTIVE: In this study, we evaluated the metabolomic profiling of cryopreserved Lipogems® tissue products and the initial lipoaspirates before microfracturing, to determine altered metabolites that could result from the non-enzymatic processing or the cryopreservation method. MATERIALS AND METHODS: Human Lipoaspirate samples (n=10) were divided in two aliquots, of which one was non-processed and the other was processed by Lipogems® device. Non-processed lipoaspirates and Lipogems® processed tissues were stored at -80°C fresh frozen (N=3 per group) or in the presence of 0.5 M dimethyl sulfoxide (DMSO) (N=7 per group). A global non-targeted metabolic profile on these samples was performed. RESULTS: Differences were observed in carbohydrate and nucleotide metabolism. These alterations translated in long chain and polyunsaturated fatty acid levels and amino acid metabolites showed divergent trends. When Lipogems® and Lipoaspirate tissue products were cryopreserved with DMSO, amino acids tended to increase in Lipogems® product. However, in the absence of DMSO aminoacids and their catabolites, tended to decrease in Lipogems® fat tissue product. CONCLUSIONS: Microfractured human adipose tissue has been shown to provide a more effective source of adult stromal cells compared to the initial lipoaspirated tissue material. These could be, according to our findings, due to the changes in the metabolic profile of lipoaspirate tissues products.

Original languageEnglish (US)
Pages (from-to)3249-3260
Number of pages12
JournalEuropean Review for Medical and Pharmacological Sciences
Volume22
Issue number10
StatePublished - Jan 1 2018

Fingerprint

Metabolomics
Adipose Tissue
Dimethyl Sulfoxide
Metabolome
Amino Acids
Cryopreservation
Carbohydrate Metabolism
Stromal Cells
Unsaturated Fatty Acids
Nucleotides
Fats
Equipment and Supplies

Keywords

  • Adipose tissue
  • Lipoaspirates
  • Metabolomic
  • Non-enzymatic isolation

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Metabolomic changes in human adipose tissue derived products following non-enzymatic microfacturing. / Garcia-Contreras, M.; Messaggio, F.; Mendez, Armando J; Ricordi, Camillo.

In: European Review for Medical and Pharmacological Sciences, Vol. 22, No. 10, 01.01.2018, p. 3249-3260.

Research output: Contribution to journalArticle

@article{2728a0778d1142c798a3b3d3cf1246db,
title = "Metabolomic changes in human adipose tissue derived products following non-enzymatic microfacturing",
abstract = "OBJECTIVE: In this study, we evaluated the metabolomic profiling of cryopreserved Lipogems{\circledR} tissue products and the initial lipoaspirates before microfracturing, to determine altered metabolites that could result from the non-enzymatic processing or the cryopreservation method. MATERIALS AND METHODS: Human Lipoaspirate samples (n=10) were divided in two aliquots, of which one was non-processed and the other was processed by Lipogems{\circledR} device. Non-processed lipoaspirates and Lipogems{\circledR} processed tissues were stored at -80°C fresh frozen (N=3 per group) or in the presence of 0.5 M dimethyl sulfoxide (DMSO) (N=7 per group). A global non-targeted metabolic profile on these samples was performed. RESULTS: Differences were observed in carbohydrate and nucleotide metabolism. These alterations translated in long chain and polyunsaturated fatty acid levels and amino acid metabolites showed divergent trends. When Lipogems{\circledR} and Lipoaspirate tissue products were cryopreserved with DMSO, amino acids tended to increase in Lipogems{\circledR} product. However, in the absence of DMSO aminoacids and their catabolites, tended to decrease in Lipogems{\circledR} fat tissue product. CONCLUSIONS: Microfractured human adipose tissue has been shown to provide a more effective source of adult stromal cells compared to the initial lipoaspirated tissue material. These could be, according to our findings, due to the changes in the metabolic profile of lipoaspirate tissues products.",
keywords = "Adipose tissue, Lipoaspirates, Metabolomic, Non-enzymatic isolation",
author = "M. Garcia-Contreras and F. Messaggio and Mendez, {Armando J} and Camillo Ricordi",
year = "2018",
month = "1",
day = "1",
language = "English (US)",
volume = "22",
pages = "3249--3260",
journal = "European Review for Medical and Pharmacological Sciences",
issn = "1128-3602",
publisher = "Verduci Editore",
number = "10",

}

TY - JOUR

T1 - Metabolomic changes in human adipose tissue derived products following non-enzymatic microfacturing

AU - Garcia-Contreras, M.

AU - Messaggio, F.

AU - Mendez, Armando J

AU - Ricordi, Camillo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - OBJECTIVE: In this study, we evaluated the metabolomic profiling of cryopreserved Lipogems® tissue products and the initial lipoaspirates before microfracturing, to determine altered metabolites that could result from the non-enzymatic processing or the cryopreservation method. MATERIALS AND METHODS: Human Lipoaspirate samples (n=10) were divided in two aliquots, of which one was non-processed and the other was processed by Lipogems® device. Non-processed lipoaspirates and Lipogems® processed tissues were stored at -80°C fresh frozen (N=3 per group) or in the presence of 0.5 M dimethyl sulfoxide (DMSO) (N=7 per group). A global non-targeted metabolic profile on these samples was performed. RESULTS: Differences were observed in carbohydrate and nucleotide metabolism. These alterations translated in long chain and polyunsaturated fatty acid levels and amino acid metabolites showed divergent trends. When Lipogems® and Lipoaspirate tissue products were cryopreserved with DMSO, amino acids tended to increase in Lipogems® product. However, in the absence of DMSO aminoacids and their catabolites, tended to decrease in Lipogems® fat tissue product. CONCLUSIONS: Microfractured human adipose tissue has been shown to provide a more effective source of adult stromal cells compared to the initial lipoaspirated tissue material. These could be, according to our findings, due to the changes in the metabolic profile of lipoaspirate tissues products.

AB - OBJECTIVE: In this study, we evaluated the metabolomic profiling of cryopreserved Lipogems® tissue products and the initial lipoaspirates before microfracturing, to determine altered metabolites that could result from the non-enzymatic processing or the cryopreservation method. MATERIALS AND METHODS: Human Lipoaspirate samples (n=10) were divided in two aliquots, of which one was non-processed and the other was processed by Lipogems® device. Non-processed lipoaspirates and Lipogems® processed tissues were stored at -80°C fresh frozen (N=3 per group) or in the presence of 0.5 M dimethyl sulfoxide (DMSO) (N=7 per group). A global non-targeted metabolic profile on these samples was performed. RESULTS: Differences were observed in carbohydrate and nucleotide metabolism. These alterations translated in long chain and polyunsaturated fatty acid levels and amino acid metabolites showed divergent trends. When Lipogems® and Lipoaspirate tissue products were cryopreserved with DMSO, amino acids tended to increase in Lipogems® product. However, in the absence of DMSO aminoacids and their catabolites, tended to decrease in Lipogems® fat tissue product. CONCLUSIONS: Microfractured human adipose tissue has been shown to provide a more effective source of adult stromal cells compared to the initial lipoaspirated tissue material. These could be, according to our findings, due to the changes in the metabolic profile of lipoaspirate tissues products.

KW - Adipose tissue

KW - Lipoaspirates

KW - Metabolomic

KW - Non-enzymatic isolation

UR - http://www.scopus.com/inward/record.url?scp=85047885312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047885312&partnerID=8YFLogxK

M3 - Article

C2 - 29863273

AN - SCOPUS:85047885312

VL - 22

SP - 3249

EP - 3260

JO - European Review for Medical and Pharmacological Sciences

JF - European Review for Medical and Pharmacological Sciences

SN - 1128-3602

IS - 10

ER -